These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7729473

  • 1. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
    Canfield CJ, Pudney M, Gutteridge WE.
    Exp Parasitol; 1995 May; 80(3):373-81. PubMed ID: 7729473
    [Abstract] [Full Text] [Related]

  • 2. Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs.
    McRobert L, Jiang S, Stead A, McConkey GA.
    Exp Parasitol; 2005 Nov; 111(3):178-81. PubMed ID: 16140296
    [Abstract] [Full Text] [Related]

  • 3. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
    Touze JE, Fourcade L, Pradines B, Hovette P, Paule P, Heno P.
    Med Trop (Mars); 2002 Nov; 62(3):219-24. PubMed ID: 12244914
    [Abstract] [Full Text] [Related]

  • 4. Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
    Nduati EW, Kamau EM.
    Acta Trop; 2006 Mar; 97(3):357-63. PubMed ID: 16457769
    [Abstract] [Full Text] [Related]

  • 5. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
    Edstein MD, Kotecka BM, Anderson KL, Pombo DJ, Kyle DE, Rieckmann KH, Good MF.
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
    [No Abstract] [Full Text] [Related]

  • 6. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
    Fivelman QL, Adagu IS, Warhurst DC.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4097-102. PubMed ID: 15504827
    [Abstract] [Full Text] [Related]

  • 7. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
    Thapar MM, Gil JP, Björkman A.
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
    Lütgendorf C, Rojanawatsirivet C, Wernsdorfer G, Sirichaisinthop J, Kollaritsch H, Wernsdorfer WH.
    Wien Klin Wochenschr; 2006 Jan; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
    [Abstract] [Full Text] [Related]

  • 9. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L, Pradines B, Parzy D, Durand R, Bigot P, Le Bras J.
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [Abstract] [Full Text] [Related]

  • 10. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
    Vivas L, Rattray L, Stewart LB, Robinson BL, Fugmann B, Haynes RK, Peters W, Croft SL.
    J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
    [Abstract] [Full Text] [Related]

  • 11. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.
    Butcher GA, Sinden RE.
    Am J Trop Med Hyg; 2003 Jan; 68(1):111-4. PubMed ID: 12556158
    [Abstract] [Full Text] [Related]

  • 12. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M, Grobusch MP, Gascon J, Matteelli A, Laferl H, Bisoffi Z, Ehrhardt S, Cuadros J, Hatz C, Gjorup I, McWhinney P, Beran J, da Cunha S, Schulze M, Kollaritsch H, Kern P, Fry G, Richter J, European Network on Surveillance of Imported Infectious Diseases.
    J Infect Dis; 2004 Nov 01; 190(9):1541-6. PubMed ID: 15478057
    [Abstract] [Full Text] [Related]

  • 13. Plasmodium falciparum outwits Malarone, protector of travellers.
    Crabb C.
    Bull World Health Organ; 2003 Nov 01; 81(5):382-3. PubMed ID: 12856058
    [No Abstract] [Full Text] [Related]

  • 14. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
    Pattanapanyasat K, Kotipun K, Yongvanitchit K, Hider RC, Kyle DE, Heppner DG, Walsh DS.
    Southeast Asian J Trop Med Public Health; 2001 Mar 01; 32(1):64-9. PubMed ID: 11485097
    [Abstract] [Full Text] [Related]

  • 15. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J.
    Med Trop (Mars); 2002 Mar 01; 62(3):232-6. PubMed ID: 12244917
    [Abstract] [Full Text] [Related]

  • 16. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK, Van Vugt M, Paiphun L, Slight T, Looareesuwan S, White NJ, Nosten F.
    Am J Trop Med Hyg; 2005 Aug 01; 73(2):267-8. PubMed ID: 16103586
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK.
    Am J Trop Med Hyg; 2003 Aug 01; 69(2):179-83. PubMed ID: 14506774
    [Abstract] [Full Text] [Related]

  • 18. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct 01; 11(61):131-6. PubMed ID: 12378742
    [Abstract] [Full Text] [Related]

  • 19. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
    Camus D, Dutoit E, Masson V, Inglebert P, Delhaes L.
    Med Trop (Mars); 2002 Oct 01; 62(3):225-8. PubMed ID: 12244915
    [Abstract] [Full Text] [Related]

  • 20. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN, Kain KC.
    Expert Rev Anti Infect Ther; 2005 Dec 01; 3(6):849-61. PubMed ID: 16307498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.